Vol. 284, Issue 2, R607-R610, February 2003
REPORT
Expression of smooth muscle MyHC B in blood vessels
of hypertrophied heart in experimentally hypertensive
rats
Katharina
Wetzel1,
Ovidiu
Baltatu1,
Benno
Nafz2,
Pontus
B.
Persson2,
Hannelore
Haase1, and
Ingo
Morano1,2
1 Max Delbrück Center for Molecular Medicine,
13122 Berlin-Buch; and 2 Johannes-Müller-Institute
of Physiology, Humboldt-University, Medical Faculty (Charité),
Berlin, Germany
 |
ABSTRACT |
We demonstrated recently a significantly
lower fraction of cardiac precapillary arterioles that expressed smooth
muscle myosin heavy chain (MyHC) B (SMB) in spontaneously hypertensive
rats. To clarify whether this reduction of SMB expression is of genetic origin, we investigated SMB expression in cardiac precapillary arterioles of normotensive and experimentally hypertensive rats (one
clip, one kidney or ANG II minipump). We observed similar SMB
expression patterns in precapillary arterioles of experimentally hypertensive rats compared with normotensive controls. These
observations suggest that the downregulation of SMB in spontaneously
hypertensive rats is of genetic origin rather than an adaptive response
to chronically enhanced blood pressure and cardiac hypertrophy.
hypertrophy; hypertension; myosin heavy chain
 |
INTRODUCTION |
TYPE II MYOSIN, a
hexamer composed of two myosin heavy chains (MyHCs), each associated
with two types of light chains (MyLCs), is the molecular motor of all
muscle cells. (17). At least seven different genes coding
for MyHCs and seven genes coding for MyLCs exist (15, 20,
24). Splicing of exon 39 generates SM1 (204 kDa), and inclusion
of exon 39 yields SM2 (200 kDa) (1, 10, 19, 21, 23, 27).
Splicing of exon 5b generates the A forms; its inclusion generates the
B forms (10, 19, 21, 23).
Smooth muscle MyHC B (SMB) revealed an approximately twofold higher
actin-activated Mg2+-ATPase activity, attachment time
(14), and actin filament movement velocity in the in vitro
motility assay than smooth muscle MyHC A (SMA; Refs. 13,
22). Recently, an SMB knockout mouse model confirmed
higher force generation and cross-bridge cycling kinetics of smooth
muscle preparations in the presence of SMB (2).
The phasic smooth muscle tissue from the antrum region of the
stomach (8), urinary bladder (11, 27, 28),
esophageal body (25), intestine (27),
trachea, and airway (16) contains predominantly the SMB
isoform, whereas smooth muscle cells from myometrium
(27), urethra (11), lower esophageal
sphincter (25), fundus region of the stomach
(8), the corpus cavernosum (7), aorta
(6, 27), and vena cava (27) contain
predominantly the SMA isoform. In contrast, precapillary arterioles
expressed considerable amounts of the B form (6, 12, 16,
26).
Normotensive rats revealed a higher fraction of precapillary arterioles
with detectable SMB expression than spontaneously hypertensive rats
(SHRs) of the stroke-prone strain (26). To investigate
whether this difference is of genetic origin or represents an adaptive
response to chronically elevated blood pressure and cardiac
hypertrophy, we determined the expression of SMB in cardiac vessels in
two experimental models of hypertension-induced cardiac hypertrophy [1
clip, 1 kidney (1C1K); ANG II minipump].
 |
MATERIALS AND METHODS |
Surgical procedures and tissue preparations.
Renovascular hypertension was induced by unilateral stenosis of the
left renal artery (0.22-mm silver clip) in 6-wk-old male Sprague-Dawley
(SD) rats (1C1K). In matched sham-operated control animals, the renal
artery was partially exposed by removal of rounding tissue. After 3 days, blood pressure was measured in the femoral artery between 9 AM
and 11 AM in the freely moving animal (P23Db Statham pressure
transducer, 4600 Gould pressure processor). Animals were killed 6 wk
later. For continuous subcutaneous ANG II infusion, 3-mo-old male SD
rats received ANG II by osmotic pump for 7 days (Alzet, model 2001, Alza) with an infusion rate of 250 ng ANG
II · kg
1 · min
1.
Blood pressure was measured by the tail-cuff method under light and
short (2 min) ether anesthesia.
The animals were weighed and killed by cervical dislocation; the heart
was quickly excised, blotted, and weighed; and the atria and right
ventricles were removed. The left ventricle was immediately frozen in
2-methylbutane and stored at
80°C.
Immunofluorescence microscopy.
Preparation of cryostat sections (5 µm thickness), fixation, and
immunolabeling were performed as recently described (26) using a rabbit anti-SMB antibody (a25K/50K; cf. Ref. 22)
and mouse anti-smooth muscle-actin antibody (aSM-actin, Boehringer, Germany). Primary antibodies were visualized as described previously (26). Nuclei were stained simultaneously by
4',6-diamidino-2-phenylindole dihydrochloride (DAPI; Sigma).
Immunolabeling was evaluated with an Axioplan fluorescence microscope
(Zeiss, Oberkochen, Germany) using appropriate filter systems.
Micrographs were taken with an MC 100 automatic camera (Zeiss). All
aSM-actin-positive and a25K/50K-positive vessels in a section were
counted (2 sections/ventricle; 6 animals/group). The fraction of
a25K/50K-positive vessels was expressed in percentage of vessels
detected by aSM-actin staining.
Statistical evaluation.
Results are expressed as means ± SE. Significance analysis was
performed with the Student's t-test.
 |
RESULTS |
Expression of SMB was analyzed by immunofluorescence microscopy of
cryostat sections of rat left ventricle using a double-labeling method
(cf. Ref. 26). The specific aSM-actin antibody was used to
identify cardiac vessels, and the a25K/50K antibody was used for
simultaneous detection of the SMB isoform. Cardiomyocytes did not react
with these antibodies (Fig. 1).

View larger version (68K):
[in this window]
[in a new window]
|
Fig. 1.
Immunofluorescence micrograph of a left rat ventricle
double-labeled with a25K/50K (A) and anti-smooth
muscle-actin (aSM-actin) antibodies (B). Primary antibodies
were visualized with species-specific secondary antibodies conjugated
with Cy3 (A) and DTAF (B). Most small vessels of
ventricular tissue were labeled with both antibodies, whereas all large
vessels were only labeled with the aSM-actin antibody. Arrows mark a
small vessel without smooth muscle myosin heavy chain B
(SMB).
|
|
In normal adult rats, the labeling pattern differs in blood vessels of
different size. Most small vessels with wall thickness <13 µm and
lumen diameter <18 µm of normal left ventricles were labeled with
a25K/50K (Fig. 1A) and aSM-actin antibodies (Fig. 1B). Staining of nuclei with DAPI showed that the
SMB-positive vessels were surrounded by a single layer of smooth muscle
cells (precapillary arterioles) (not shown). Large vessels were
characterized by a wall thickness of
13 µm and a lumen diameter of
18 µm. In all sections the percentage of large vessels represented
barely 2% of all blood vessels. All large vessels reacted only with
aSM-actin but not with a25K/50K antibody (Fig. 1B).
In another set of experiments, we compared the fraction of SMB-positive
precapillary arterioles, i.e., blood vessels with wall thickness <13
µm and lumen diameter <18 µm and single smooth muscle cell
layer, of the left ventricle of normotensive with experimentally hypertensive rats (1C1K and ANG II treated). Similar to
control rats, only precapillary arterioles of hypertensive rats reacted
with a25K/50K. The fractions of SMB-positive vessels ranged between
66.9 and 71.5% of all precapillary arterioles investigated (Table
1). This was not significantly
different compared with the corresponding control animals
(range 62.4-67.8%; Table 1).
View this table:
[in this window]
[in a new window]
|
Table 1.
Expression of SMB in precapillary arterioles in percentage of whole
precapillary arterioles of 1C1K ANG II-infused, and corresponding
control rats
|
|
Blood pressure of 1C1K and ANG II animals was significantly higher
(P < 0.01) compared with the corresponding controls
(Tables 2 and
3). In both experimental
hypertension models, heart weight and the heart-to-body weight
ratio were significantly (P < 0.05) higher than the
respective control rats (Tables 2 and 3).
View this table:
[in this window]
[in a new window]
|
Table 2.
Mean BP, body weight, heart weight, and ratio of heart weight to
body weight of 1C1K and control male rats
|
|
View this table:
[in this window]
[in a new window]
|
Table 3.
Mean BP, body weight, heart weight, and ratio of heart weight to
body weight of ANG II-implanted and control rats
|
|
 |
DISCUSSION |
In a previous study we reported a significantly lower fraction of
SMB-expressing ventricular precapillary arterioles in SHRs (26). To determine whether this difference is genetically
determined or represents an adaptive response to hypertension and
hypertrophy, we investigated the expression of SMB in cardiac vessels
in two experimental models of chronic hypertension, namely in a 1C1K model of renal artery stenosis and in an ANG II minipump model. Between
62.4 and 67.8% of cardiac precapillary arterioles expressed SMB in
control SD rats. This is in accordance with recent observations in
Wistar-Kyoto rats (26). Both occlusion of renal artery,
which is known to activate the renin-angiotensin system, as well as chronic infusion of the vasoconstrictor ANG II, induced hypertension and cardiac hypertrophy (cf. also Refs. 4 and 9). We found no different pattern of SMB expression in precapillary arterioles in
experimental hypertension (range between 66.9 and 71.5% SMB-expressing precapillary arterioles) compared with normotensive controls. Therefore, we suggest that the abnormal SMB expression pattern in
ventricular precapillary arterioles of SHRs is of genetic origin rather
than the result of an adaptive response to chronically enhanced blood
pressure and cardiac hypertrophy.
The physiological importance of SMB expression in most of the
precapillary arterioles still has to be elucidated. Interestingly, precapillary arterioles are main targets of sympathetic regulation (3, 18). In addition, smooth muscle cells of the corpus
cavernosum, which are tightly innervated with sympathetic nerves,
expressed high amounts of SMB (7). It seems interesting to
demonstrate whether cardiac blood vessels regulate their responsiveness
to sympathetic innervation by differential expression of 5'-spliced smooth muscle MyHC isoenzymes. It could be demonstrated that
actin-activated ATPase activity, velocity of actin filament movements
in the in vitro motility assay, attachment time in the laser trap
study, as well as isometric force development and shortening velocity of SMB isoforms are higher than SMA isoforms (2, 13, 14, 22). These functional features, therefore, could confer an
accelerated contractile response of SMB-expressing precapillary
arterioles to sympathetic stimulation.
 |
ACKNOWLEDGEMENTS |
The technical assistance of E. Kotitschke is gratefully
acknowledged. We thank Dr. G. Lutsch for engagement and permanent help.
 |
FOOTNOTES |
This work was supported by Deutsche Forschungsgemeinschaft Grant No.
362/16-2 to I. Morano.
Address for reprint requests and other correspondence: I. Morano, Max Delbrück Center for Molecular Medicine, Robert
Rössle-Strasse 10, 13122 Berlin-Buch, Germany (E-mail:
imorano{at}mdc-berlin.de).
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement"
in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
10.1152/ajpregu.00578.2002
Received 17 September 2002; accepted in final form 23 October 2002.
 |
REFERENCES |
1.
Babij, P.
Tissue-specific and developmentally regulated alternative splicing of a visceral isoform of smooth muscle myosin heavy chain.
Nucleic Acids Res
21:
1467-1471,
1993[Abstract/Free Full Text].
2.
Babu, GJ,
Loukianov E,
Loukianov T,
Pyne GJ,
Huke S,
Osol G,
Low RB,
Paul RJ,
and
Periasamy M.
Loss of SMB myosin affects muscle shortening velocity and maximal force development.
Nat Cell Biol
3:
1025-1029,
2001[Web of Science][Medline].
3.
Baez, LS,
Feldmann SM,
and
Gootman PM.
Central neural influence on precapillary microvessels and sphincter.
Am J Physiol Heart Circ Physiol
233:
H141-H147,
1977[Abstract/Free Full Text].
4.
Daemen, MJAP,
Lombardi DM,
Bosman FT,
and
Schwartz SM.
Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall.
Circ Res
68:
450-456,
1991[Abstract/Free Full Text].
5.
Dickinson, CJ,
and
Lawrence JR.
A slowly developing pressor response to small concentrations of angiotensin.
Lancet
1:
1354-1356,
1963[Web of Science][Medline].
6.
DiSanto, ME,
Cox RH,
Wang Z,
and
Chacko S.
NH2-terminal-inserted myosin II heavy chain is expressed in smooth muscle of small muscular arteries.
Am J Physiol Cell Physiol
272:
C1532-C1542,
1997[Abstract/Free Full Text].
7.
DiSanto, ME,
Wang Z,
Menon C,
Zheng Y,
Chacko T,
Hypolite J,
Broderick G,
Wein AJ,
and
Chacko S.
Expression of myosin isoforms in smooth muscle cells in the corpus cavernosum penis.
Am J Physiol Cell Physiol
275:
C976-C987,
1998[Abstract/Free Full Text].
8.
Eddinger, TJ,
and
Meer DP.
Single rabbit stomach smooth muscle cell myosin heavy chain SMB expression and shortening velocity.
Am J Physiol Cell Physiol
280:
C229-C316,
2001.
9.
Griffin, SA,
Brown WCB,
MacPherson F,
McGrath JC,
Wilson VG,
Korsgaard N,
Mulvany MJ,
and
Lever AF.
Angiotensin II causes vascular hypertrophy in part by non-precursor mechanism.
Hypertension
17:
626-635,
1991[Abstract/Free Full Text].
10.
Hamada, Y,
Yanagisawa M,
Katsugarawa Y,
Coleman JR,
Nagata S,
Matsuda G,
and
Masaki T.
Distinct vascular, and intestinal smooth muscle myosin heavy chain mRNAs are encoded by a single-copy gene in the chicken.
Biochem Biophys Res Commun
170:
53-58,
1990[Web of Science][Medline].
11.
Hypolite, JA,
DiSanto ME,
Zheng Y,
Chang S,
Wein AJ,
and
Chacko S.
Regional variation in myosin isoforms, and phosphorylation at the resting tone in urinary bladder smooth muscle.
Am J Physiol Cell Physiol
280:
C254-C264,
2001[Abstract/Free Full Text].
12.
Jones, R,
Steudel W,
White S,
Jacobsen M,
and
Low R.
Microvessel precursor smooth muscle cells express head-inserted smooth muscle myosin heavy chain SMB isoform in hyperoxic pulmonary hypertension.
Cell Tissue Res
295:
453-465,
1999[Web of Science][Medline].
13.
Kelley, CA,
Takahashi M,
Yu JH,
and
Adelstein RS.
An insert of seven amino acids confers functional differences between smooth muscle myosins from the intestines and vasculature.
J Biol Chem
268:
12848-12854,
1993[Abstract/Free Full Text].
14.
Lauzon, AM,
Tyska MJ,
Rovner AS,
Freyzon Y,
Warshaw DM,
and
Trybus KM.
A 7-amino-acid insert in the heavy chain nucleotide binding loop alters the kinetics of smooth muscle myosin in the laser trap.
J Muscle Res Cell Motil
19:
825-837,
1998[Web of Science][Medline].
15.
Leinwand, LA,
Fournier REK,
Nadal-Ginard B,
and
Shows TB.
Isolation and characterization of human myosin heavy chain genes.
Proc Natl Acad Sci USA
80:
3716-3720,
1983[Abstract/Free Full Text].
16.
Low, RB,
Mitchell J,
Woodcock-Mitchell J,
Rovner AS,
and
White SL.
Smooth-muscle myosin heavy-chain SMB isoform expression in developing and adult rat lung.
Am J Respir Cell Mol Biol
20:
651-657,
1999[Abstract/Free Full Text].
17.
Lowey, S,
and
Risby D.
Light chains from fast and slow muscle myosins.
Nature
225:
81-85,
1971.
18.
Luff, SE,
Hengstenberger SG,
McLachlan EM,
and
Andersen WP.
Distribution of sympathetic neuroeffector junctions in the juxtaglomerular region of the rabbit kidney.
J Auton Nerv Syst
40:
239-252,
1992[Web of Science][Medline].
19.
Nagai, R,
Kuro-o M,
Babij P,
and
Periasamy M.
Identification of two types of smooth muscle myosin heavy chain isoforms by cDNA cloning and immunoblot analysis.
J Biol Chem
264:
9725-9737,
1989.
20.
Ngyuyen, H,
Gubits R,
Wydro R,
and
Nadal-Ginard B.
Sarcomeric myosin heavy chain is coded by a highly conserved multigene family.
Proc Natl Acad Sci USA
79:
5222-5225,
1982.
21.
Rovner, AS,
Thompson MM,
and
Murphy RA.
Two different myosin heavy chains are found in smooth muscle.
Am J Physiol Cell Physiol
250:
C861-C870,
1986[Abstract/Free Full Text].
22.
Rovner, A,
Freyzon Y,
and
Trybus KM.
An insert in the motor domain determines the functional properties of expressed smooth muscle myosin isoforms.
J Muscle Res Cell Motil
18:
103-110,
1997[Web of Science][Medline].
23.
Somlyo, AP.
Myosin isoforms in smooth muscle: how may they affect function, and structure?
J Muscle Res Cell Motil
14:
557-563,
1993[Web of Science][Medline].
24.
Swynghedauw, B.
Developmental and functional adaptation of contractile proteins in cardiac and skeletal muscles.
Physiol Rev
66:
710-771,
1986[Abstract/Free Full Text].
25.
Szymanski, PT,
Chacko TK,
Rovner AS,
and
Goyal RJ.
Differences in contractile protein content, and isoforms in phasic and tonic smooth muscles.
Am J Physiol Cell Physiol
275:
C684-C692,
1998[Abstract/Free Full Text].
26.
Wetzel, U,
Lutsch G,
Haase H,
Ganten U,
and
Morano I.
Expression of smooth muscle heavy chain B in cardiac vessels of normotensive, and hypertensive rats.
Circ Res
83:
204-209,
1998[Abstract/Free Full Text].
27.
White, S,
Martin A,
and
Periasamy M.
Identification of a novel smooth muscle myosin heavy chain cDNA: isoform diversity in the S1 head region.
Am J Physiol Cell Physiol
264:
C1252-C1258,
1993[Abstract/Free Full Text].
28.
White, S,
Zhou MY,
Low RB,
and
Periasamy M.
Myosin heavy chain isoform expression in rat smooth muscle development.
Am J Physiol Cell Physiol
275:
C581-C589,
1998[Abstract/Free Full Text].
Am J Physiol Regul Integr Comp Physiol 284(2):R607-R610
0363-6119/03 $5.00
Copyright © 2003 the American Physiological Society